Citigroup issued a neutral rating on Genpact shares, while TD Cowen reduced its price target and set a buy rating.
4 reports, 3 independent
Updated Wed 00:00
No new developments lately
- Reports
- 4
- Developments
- 3
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup issued a neutral rating on Genpact shares, while TD Cowen reduced its price target and set a buy rating.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Citigroup raised its price target for Genpact.1 source
Citigroup and TD Cowen boosted target prices for Genpact shares.1 source
Citigroup rated Genpact neutrally; TD Cowen cut price target and upgraded rating.1 source
Keep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Genpact
New York professional services firm
-
TD Cowen
American investment bank
Related events
- Bank of America updated its price objective and rating, while Citigroup reissued a neutral rating on Biogen shares.
- Citigroup upgraded its target price and gave a buy rating for Fortrea.
- Citigroup, Scotiabank, Morgan Stanley, and TD Cowen issued rating and price target updates for Pinnacle West Capital Corporation.
- Citigroup and Jefferies Financial Group raised their price targets and issued buy ratings for Beauty.
- Morgan Stanley lowered its rating and set a target price, while Citigroup raised its price target and gave a neutral rating for Vornado Realty Trust.